Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Pharm ; 429(1-2): 78-83, 2012 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-22465630

RESUMEN

The aptitude of ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson's disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using limonene or by application of electric fields. Absorption improvement was accompanied by the important reduction of the lag time; at once the time required to reach the steady state plasma concentration was drastically decreased. On the basis of these results we could assume that clinical application of ropinirole by buccal delivery is feasible.


Asunto(s)
Antiparkinsonianos/farmacocinética , Sistemas de Liberación de Medicamentos , Indoles/farmacocinética , Mucosa Bucal/metabolismo , Adyuvantes Farmacéuticos/química , Administración Bucal , Animales , Antiparkinsonianos/administración & dosificación , Ciclohexenos/química , Electricidad , Estudios de Factibilidad , Indoles/administración & dosificación , Iontoforesis , Limoneno , Modelos Biológicos , Enfermedad de Parkinson/tratamiento farmacológico , Permeabilidad , Porcinos , Terpenos/química , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA